Evidence map›Paper›PMID 27629368›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Ebrahim Haroon, Andrew H Miller, Gerard Sanacora

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04592354 (Anhydrous Enol-Oxaloacetate), which is not on this map. Cited by 329 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
329citing papers in PubMed, 5 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04592354 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors

TypeinterventionalSponsorTerra Biological LLCRan2020 to 2021Enrolled40ConditionsTreatment of Fatigue After Resolution of COVID-19 InfectionArmsOxaloacetate Medical Food/Dietary Supplement
3 · Its place in the literature

Who cites it

329 citing papers in PubMed, 5 syntheses or guidelines pooled it, 548 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Reduced prefrontal total choline MRS levels characterize the neurodevelopmental phenotype of bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

269 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ebrahim HaroonDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-8817-1116
Andrew H MillerDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
Gerard SanacoraDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Emory University · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Inflammation-Induced CNS Glutamate as a Function of Depression in Middle AgeR01MH107033 · NIMH · EMORY UNIVERSITY · PI HAROON, EBRAHIM · 2016 to 2021
$2.2M
Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2010 to 2014
$2.2M
Inflammation-Induced CNS Glutamate Changes in DepressionR01MH112076 · NIMH · EMORY UNIVERSITY · PI HAROON, EBRAHIM, MILLER, ANDREW H · 2016 to 2020
$2.0M
MR SPECTROSCOPY TO REVEAL CNS MECHANISMS OF CYTOKINE-INDUCED BEHAVIORAL CHANGEK23MH091254 · NIMH · EMORY UNIVERSITY · PI HAROON, EBRAHIM · 2010 to 2014
$883k
Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentR21MH105897 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2015 to 2016
$429k
Predictors and Targets of Response to Cytokine Antagonism in DepressionR03MH100273 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2013 to 2014
$156k
6 · The paper itself

Abstract

Increasing data indicate that inflammation and alterations in glutamate neurotransmission are two novel pathways to pathophysiology in mood disorders. The primary goal of this review is to illustrate how these two pathways may converge at the level of the glia to contribute to neuropsychiatric disease. We propose that a combination of failed clearance and exaggerated release of glutamate by glial cells during immune activation leads to glutamate increases and promotes aberrant extrasynaptic signaling through ionotropic and metabotropic glutamate receptors, ultimately resulting in synaptic dysfunction and loss. Furthermore, glutamate diffusion outside the synapse can lead to the loss of synaptic fidelity and specificity of neurotransmission, contributing to circuit dysfunction and behavioral pathology. This review examines the fundamental role of glia in the regulation of glutamate, followed by a description of the impact of inflammation on glial glutamate regulation at the cellular, molecular, and metabolic level. In addition, the role of these effects of inflammation on glia and glutamate in mood disorders will be discussed along with their translational implications.

Indexed as

InflammationMood DisordersNeurogliaSignal TransductionSynaptic TransmissionAnimalsGlutamic AcidHumansGlutamic Acid

Identifiers

PMID27629368
PMCPMC5143501
OpenAlexW2519381186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.